Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®

NCT02537574 is registered in ClinicalTrials.gov with Alkermes, Inc. as lead sponsor.

NCT NCT02537574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02537574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL®
Lead sponsor
Alkermes, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2015
Completion date
January 9, 2017
Enrollment
380 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder